Amanote Research
Register
Sign In
Effect of the Biological Drug Etanercept on Tumor Necrosis Factor-Α Levels in Psoriatic Patients
Iraqi Journal of Science
- Iraq
doi 10.24996/ijs.2018.59.2c.2
Full Text
Open PDF
Abstract
Available in
full text
Categories
Genetics
Molecular Biology
Geology
Biochemistry
Computer Science
Biotechnology
Chemistry
Date
June 27, 2018
Authors
Unknown
Publisher
University of Baghdad College of Science
Related search
Antidrug Antibody Formation During Tumor Necrosis Factor Α Inhibitor Treatment of Severe Psoriatic Patients in the Real-Life Practice
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
NEGATIVE INOTROPIC EFFECT OF TUMOR NECROSIS FACTOR-α ON THE ADULT CARDIAC MYOCYTES
The KITAKANTO Medical Journal
Additive Effect of Tumor Necrosis Factor-Α and Endotoxin on Bilirubin Cytotoxicity
Pediatric Research
Child Health
Pediatrics
Perinatology
Erratum To: Anti-Tumor Necrosis Factor-Α Therapy and Changes of Flow-Mediated Vasodilatation in Psoriatic and Rheumatoid Arthritis Patients
Internal and Emergency Medicine
Internal Medicine
Emergency Medicine
Antioxidants and Tumor Necrosis Factor-Α in Patients With Pulmonary Tuberculosis
Journal of High Institute of Public Health
Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Fcγ-Receptor Signaling Augments the LPS-stimulated Increase in Serum Tumor Necrosis Factor-Α Levels
American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
Infliximab (Anti–Tumor Necrosis Factor Α Antibody)
Archives of Dermatology
Myocardial Infarction Marker Levels Are Influenced by Prothrombin and Tumor Necrosis Factor-Α Gene Polymorphisms in Young Patients
Cytokine
Biochemistry
Allergy
Immunology
Hematology
Molecular Biology